Speaker Profile
Steven G. Coca

Steven G. Coca BS, DO, MS

Nephrology
New York, New York, United States of America

Connect with the speaker?

Dr. Steven Coca is a former graduate from University of New England College of Osteopathic Medicine. He completed his medical residency and clinical nephrology fellowship at Yale University and Yale New Haven Hospital in CT. He also received a Master’s Degree in Epidemiology and Public Health during his training at Yale.

He was on faculty in the Section of Nephrology for 5 years as an Assistant Professor. Currently, he is an Associate Professor of Medicine at Icahn School of Medicine at Mount Sinai. He has been an active investigator in three large NIH-funded consortiums: the Translational Research in Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) consortium; the Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) consortium; and the CKD Biomarkers Consortium.

Dr. Coca is also the PI of an ancillary study to the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial and a member of the newly formed Drug Development Tools for Kidney Disease (DDT-KD) Consortium, sponsored by the Critical Path Institute. His major research areas include using newer biomarkers to aide risk-stratification for outcomes in acute kidney injury and chronic kidney disease. His major clinical interests include AKI, CKD, electrolyte disorders, hypertension, and cardiorenal syndrome.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)